Baker McKenzie Baker McKenzie
How Can We Help?
  • Home
  • Expertise
  • 医疗与生命科学
Language:
中文(简体)

医疗与生命科学

Purple loop
Insight | 宣传册

Data PULSE

Our Data PULSE platform helps you navigate the complex landscape of data, regulatory and IP protection concerns at each stage of the medical product life cycle.
Read More

Healthcare and life sciences companies face immense disruption. The increasing interplay between drugs, devices and tech, growing competition from biosimilars, generics and connected tech players as well as cost pressures impacting groundbreaking therapies and pipeline products have created a pressure point for change and agility.

Rise above economic volatility, supply chain issues and the uneven pace of regulation to find stability. Get the right integrated advice to build a long-term pipeline of innovative products, expand reach to new patients and markets, maximize operational efficiency and demonstrate efficacy.

Visit InsightPlus for our latest legal updates covering Healthcare & Life Sciences developments across the globe

Insight | 书籍
Doing Business in the United Arab Emirates 2023
Comprehensive guide to understanding the current investment and legal landscape in the UAE.
Insight | Podcast
Talking M&A
From navigating the complexities of carve-outs or tech transactions to cross-border trends, gain expert insights and uncover key topics in a complex transactional landscape.
Insight | 书籍
Ukrainian Laws in Wartime
Our guide provides an overview of the key features of wartime legislation.
Insight | 宣传册
The Year Ahead: Global Disputes Forecast 2023 Report
Explore key disputes trends and examine our detailed analysis of sectoral and region-specific developments, to prepare your organization for The Year Ahead.
Insight | 书籍
Guide to IPOs for Biotech and Pharma Companies
Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.
Insight | 客户/法律动态
Waiting for your MDR Certificates? 5 takeaways on the intended extension to transitional periods
The European Commission finally confirmed that it intends to extend the transitional period under the Medical Devices Regulation 2017/745.
Insight | 书籍
Global Public M&A Guide
Our Global Public M&A Guide provides an overview of key legal considerations associated with public M&A transactions across the globe.
Insight | 书籍
Pharmaceutical Trademark Trends
Our trends report gives a summary of key issues to consider from a trademark perspective.
Insight | 书籍
Global Attorney-Client Privilege Guide
The most comprehensive guide of its kind, the Global Attorney-Client Privilege Guide is an interactive resource covering the law and best practices on privilege in 34 key jurisdictions.
Insight | 书籍
Digital Healthcare Guide Philippines
Read more about the regulatory environment for digital health, medical devices, clinical trial regulations, telemedicine and the potential legal issues.
Insight | 客户/法律动态
The European Health Data Space - A Trojan Horse for Pharma and Medtech?
The draft EHDS is flying under the radar for some industry players and is just one part of a tidal wave of EU data legislation coming down the track.
View All Insight
News | 奖项
Chambers Global 2023 Ranks Baker McKenzie in 316 Practices
Chambers Global has released its 2023 guide, ranking Baker McKenzie in 316 practice areas and in 391 lawyer categories.
News | 交易公告
Baker McKenzie Advises Abbott Laboratories in $890 Million Acquisition
Baker McKenzie advised Abbott Laboratories in its acquisition of Cardiovascular Systems, Inc. in an all-cash transaction valued at approximately $890 million.
News | 交易公告
Baker McKenzie acts as legal adviser for Zur Rose Group AG in sale of Swiss business to Migros Group
Baker McKenzie Switzerland acted as legal adviser for Zur Rose Group AG in handing over its successful Swiss business to Migros.
News | 本所新闻
贝克•麦坚时欢迎美国食品药物管理局法规专家陶鑫加入华盛顿办公室
陶鑫律师加入本所不断发展壮大的食品药品监管团队；他在食品科学领域及东亚地区拥有深厚的科学背景和丰富的工作经验
News | 交易公告
Baker McKenzie Advises Minoryx in Strategic Alliance to Develop a New CNS Therapy in Europe
Baker McKenzie client Minoryx Therapeutics and the Neuraxpharm Group, announced the completion of a strategic license agreement for the European rights to leriglitazone. 
News | 交易公告
Baker McKenzie Advises Wilbur-Ellis in Merger to Form Leading Global Life Sciences and Specialty Chemicals Solutions Distribution Platform with Combined Sales of Approximately EUR 3 Billion
The deal will create a global leader in the life sciences and specialty chemicals solutions sector.
News | 交易公告
Baker McKenzie has successfully advised Uniphar plc on its acquisition of the Orspec Group
Uniphar is a diversified healthcare services business based in Ireland.
News | 交易公告
Baker McKenzie advises mRNA Victoria on agreement to manufacture mRNA vaccines in Victoria
The Firm helped facilitate agreements signed between the Victorian Government, the Federal Government, Moderna and Monash University.
News | 交易公告
Three victories for Baker McKenzie, with Goisis and Allena, in Rome, Palermo and Naples for Bio-Rad Laboratories in the immunohematology sector
Bio-Rad Laboratories, assisted by Baker McKenzie, celebrated three wins in Naples, Rome and Palermo.
News | 本所新闻
Baker McKenzie is expanding its partnership in Switzerland and worldwide
Three new partners in Switzerland and 116 new partners worldwide  
News | 交易公告
Baker McKenzie advises Galapagos on its acquisition of CellPoint and AboundBio
Both acquisitions will accelerate Galapagos' access to next generation cell therapies, significantly broaden their portfolio and will serve to position Galapagos in the next-generation cancer ...
浏览全部新闻

Ranked in the Top 10 Law Firms in the world for Life Sciences, Chambers Global

Americas

  • Ranked in Healthcare: Pharmaceutical/Medical Products Regulatory, Chambers USA 2022 (District of Columbia)
  • FDA Regulatory Firm to Watch, LMG Life Sciences Awards 2021 and 2020 (US)
  • Licensing and Collaborations Recommended Firm,  LMG Life Sciences 2021 and 2020 (US)
  • Financial & Corporate Firm to Watch, LMG Life Sciences Awards 2019 (US)
  • Band 1 for Life Sciences, Chambers Latin America 2021 - 2023 (Mexico)
  • Band 2 for Life Sciences and Healthcare, Chambers Latin America 2023 (Peru)
  • Tier 1 for Life Sciences and Healthcare, Legal 500 Latin America 2022 - 2023 (Argentina)
  • Tier 1 for Life Sciences, Legal 500 Latin America 2023 (Mexico)
  • Tier 2 for Life Sciences, Legal 500 Latin America 2023 (Colombia)

Europe, Middle East and Africa

  • Regulatory Firm of the Year, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Türkiye Firm of the Year, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Impact Deal - Vifor Pharma / Sanifit, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Band 1 for Life Sciences, Chambers Europe 2022 (Hungary and Russia)
  • Band 2 for Life Sciences, Chambers Europe 2022 (Germany and Spain)
  • Tier 1 for Healthcare & Life Sciences (Industry Focus and Regulatory), Legal 500 EMEA 2022 (Germany)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 EMEA 2022 (France, Italy, Spain)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 UK 2023 (London)
  • Law Firm of the Year for Health and Research, Top Legal Industry Awards (Italy)

Asia Pacific

  • Medical and Healthcare Law Firm of the Year, Asian Legal Business Southeast Asia Law Awards 2017 to 2021
  • Band 1 for Life Sciences, Chambers Global 2014 to 2023 and Chambers Asia Pacific 2014 to 2023
  • Band 2 for Life Sciences, Chambers Asia Pacific 2023 (Australia)
  • Band 2 for Life Sciences (International Firms), Chambers Asia Pacific 2021 (China)
  • Tier 1 for Healthcare and Life Sciences (Foreign Firms), Legal 500 Asia Pacific 2023 (China)

How We Can Help

Explore Healthcare & Life Sciences

HLS Hub

Healthcare & Life Sciences Hub

Stay apprised on key market trends, risks, opportunities and legal issues through our dedicated resources hub.

Healthtech and Biotech M&A

The healthcare tech and biotech industries shifted fundamentally during the pandemic. Enthusiasm for dealmaking continues to be a growth area.

>> 16-minute listen

FT Big Deal Series: The Healthtech Sector’s Spectacular Surge in SPACs and de-SPACS

A three minute video discussing how the pandemic triggered a significant rise in SPAC investments in the healthtech sector.


healthcare icons on blue backgrounc

Healthcare & Life Sciences Supply Chain Webinar Series 

Focuses on the trends, issues and opportunities along each stage of supply chain life cycle for healthcare and life sciences companies.

Flares of different colored light against a black background

Guide to IPOs for Biotech and Pharma Companies

Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.


Global Healthcare & Life Sciences Webinar Series

Aims to share legal industry insights and provide practical guidance in the context of today's evolving world.
about-healthcare

About Us

Learn about our Global Healthcare & Life Sciences Industry Group in 5 minutes

Hyper-Hybridity

Explores trends and opportunities in digital health from the perspective of three key players in the ecosystem: healthcare and life sciences organizations, technology companies and investors

Healthcare MapApp

Access real-time information on the laws and regulations affecting the healthcare and life sciences industries in more than 50 countries

Clinical Trials Handbook

Outlines the legal framework governing clinical trials of medicinal products in 34 jurisdictions
Banner for Promoting Medical Products Handbook

Promoting Medical Products Globally

Understand legal developments and regulations related to ethical business interactions between medical companies and healthcare professionals in 35 countries

Key Contacts